-+ 0.00%
-+ 0.00%
-+ 0.00%

Royalty Pharma Q4 Earnings Report: What Investors Need to Know

Benzinga·02/11/2026 12:06:08
Listen to the news

The earnings results for Royalty Pharma (NASDAQ:RPRX) for Q4 were made public on Wednesday, February 11, 2026 at 07:00 AM.

Here's a comprehensive overview of the announcement.

Earnings

Royalty Pharma beat estimated earnings by 10.53%, reporting an EPS of $1.47 versus an estimate of $1.33.

Revenue was up $28.00 million from the same period last year.

Performance in Previous Earnings

In the previous quarter, the company beat on EPS by $0.1, resulting in a 0.89% increase change in the share price the following day.

Here's a look at Royalty Pharma's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate 1.07 1.05 0.950 1.05
EPS Actual 1.17 1.14 1.057 1.16
Revenue Estimate 779.42M 690.73M 724.69M 743.60M
Revenue Actual 609.00M 579.00M 568.00M 594.00M

To track all earnings releases for Royalty Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.